Corbus Pharmaceuticals Holdings, Inc. · NASDAQ:CRBP
Citadel Advisors LLC's stake in Corbus Pharmaceuticals Holdings, Inc. fell to 1.10% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Citadel Advisors LLC's stake in Corbus Pharmaceuticals Holdings, Inc. fell to 1.10%, 206,354 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 1.10%
- Shares
- 206,354
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 7 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Citadel Advisors LLC | 0% | 0 |
| Citadel Advisors Holdings LP | 0% | 0 |
| Citadel GP LLC | 0% | 0 |
| Citadel Securities LLC | 1.10% | 206,354 |
| Citadel Securities Group LP | 1.10% | 206,354 |
| Citadel Securities GP LLC | 1.10% | 206,354 |
| Kenneth Griffin | 1.10% | 206,354 |
Source
Related
- Corbus Pharmaceuticals Holdings, Inc.
- Citadel Advisors LLC
- Corbus Pharmaceuticals Holdings, Inc. shareholders
- Schedule 13G · Citadel Advisors LLC · Nov 12, 2025
- Schedule 13G · Ra Capital Management, L.P. · Sep 30, 2026
- Form 4 · Ben Yong · Sep 15, 2026
- Form 4 · Nicacio Leonardo Viana · Aug 17, 2026
- Form 4 · Saxena Nishant C · Aug 12, 2026
- Form 4 · Cohen Yuval · Aug 10, 2026